Beckman Coulter (BEC: chart), maker of bio medical testing equipment, reported earnings of 69 cents per share, a decline of 29% on an 11% rise in sales in the fourth quarter.

Brush Engineered Materials (BW: chart) reported fourth quarter 2007 sales of $236.3 million, up $28.4 million or 14% compared to the fourth quarter of 2006. Net income for the fourth quarter was $12.3 million or 60 cents per share, diluted.

Chindex International (CHDX: chart) said that revenue for the third quarter ended December 31, 2007 was $36 million, up 19% from the revenue of $30.3 million reported in the quarter ended December 31, 2006.

Net income from continuing operations for the quarter ended December 31, 2007 was $3.9 million or earnings per basic share on continuing operations of 50 cents compared to $0.7 million or 10 cents per share a year ago.

Cott Corporation (COT: chart) revenues in the fourth quarter were $412.4 million, up 3.1% from $400.1 million in the comparable prior-year period. This increase was primarily due to an 18% improvement in the International division, mainly in the U.K., while revenues in North America declined 2.5%.

Net loss in the fourth quarter was $76.8 million or $1.07 per diluted share, compared to a net loss of $29.6 million or 41 cents per diluted share in the fourth quarter of 2006.

Lubrizol Corporation (LZ: chart) said that earnings from continuing operations for the fourth quarter ended December 31, 2007 were $59.7 million, or 86 cents per diluted share, including after tax restructuring and impairment charges of $0.6 million, or 1 cent per diluted share.

Comparable earnings from continuing operations for the fourth quarter of 2006 were $21.4 million, or 31 cents per diluted share, which included after tax restructuring and impairment charges of $28.4 million, or 41 cents per diluted share, consisting primarily of a 37 cents per diluted share non-cash charge related to the impairment of the Noveon trade name.

Weyerhaeuser (WY: chart) reported net earnings of $790 million for 2007, or $3.59 per diluted share, on net sales of $16.3 billion. This compares with net earnings of $453 million for 2006, or $1.84 per diluted share, on net sales of $18.7 billion.

For the fourth quarter 2007, net loss of 63 million, or 30 cents per diluted share, on net sales of $3.9 billion compared to $507 million, or $2.12 per diluted share, on net sales of $4.8 billion.